Northeast Orthopaedics & Sports Medicine Mar 2013 - Jan 2017
Mary Washington Healthcare Mar 2012 - Jan 2013
Metropolitan Hospital Mar 2006 - Feb 2012
New York Medical College 2007 - 2011
Rochester Institute of Technology 1997 - 2001
Bachelors, Bachelor of Science
Hospitals Medicine Healthcare Clinical Research Surgery Pediatrics Internal Medicine Emergency Medicine Orthopedic Healthcare Management Urgent Care Healthcare Information Technology
This disclosure provides peptides which have a strong affinity for the checkpoint receptor “programmed death 1” (PD-1). These peptides block the interaction of PD-1 with its ligand PD-L1 and can therefore be used for various therapeutic purposes, such as inhibiting the progression of a hyperproliferative disorder, including cancer; treating infectious diseases; enhancing a response to vaccination; treating sepsis; and promoting hair re-pigmentation or lightening of pigmented skin lesions.